[Comparison of the effectiveness of mono- and polychemotherapy for murine lymphosarcoma, resistant to apoptosis induction].
Strain-specific murine lymphosarcoma RLS, resistant to apoptosis induction, was used to demonstrate that polychemotherapy (cyclophosphamide+adriamycin+cisplatin) failed to gain any significant advantage over monotherapy with adequate doses of those drugs